Categories

Volume 6 Issue 12 (December, 2018)

Original Articles

Evaluation of cardiovascular diseases and fatty liver disease in type II diabetic patients with ultrasonography
Ishteyaque Ahmad

Background: Non-alcoholic fatty liver disease (NAFLD) is the upcoming leading cause of chronic liver disease in the United States and its prevalence is increasing worldwide. The present study was conducted to assess cardiovascular diseases and fatty liver disease in type 2 diabetic patients with ultrasonography (USG). Materials & Methods:120 patients with type II diabetes mellitus and fatty liver disease of both genders were subjected to ECG. Ultrasonography was done with Toshiba machine. Parameters such as liver echogenicity, portal vein doppler study, mesenteric fat pad thickness and carotid artery doppler study was recorded. Results: Out of 120 patients, males were 80 and females were 40. Age group <40 years had 26 fatty liver and 6 non- fatty liver patients. Age group 40-50 years had 40 fatty liver and 5 non- fatty liver patients and >50 years had 31 fatty liver patients and 12 non- fatty liver disease patients. The difference was significant (P< 0.05). Ischemia was absent in 22 and present in 13 in patients with <5 years of diabetes, absent in 26 and present in 15 in patients with 5-10 years of diabetes and absent in 24 and present in 20 in patients with >10 years of diabetes. The difference was significant (P< 0.05). LVDD was absent in 40 and present in 80 patients. Grade 1 was seen in 22, grade 2 in 20 and grade 3 in 38 patients. The difference was non- significant (P> 0.05). Conclusion: There was an association between cardiovascular risk factors and non- alcoholic fatty liver disease in patients with type II diabetes mellitus.

 
Abstract View | Download PDF | Current Issue